William Kendall Sietsema

Title: Innovations of William Kendall Sietsema

Introduction

William Kendall Sietsema is an accomplished inventor based in Norwich, NY (US). He holds a total of 4 patents that reflect his contributions to the field of pharmaceuticals. His work primarily focuses on improving the delivery and efficacy of medication.

Latest Patents

One of his latest patents involves the development of novel enteric-coated oral dosage forms of risedronate. This invention is designed to protect the risedronate active ingredient from exposure to the epithelial and mucosal tissues of the buccal cavity, pharynx, esophagus, and stomach. By doing so, it aims to prevent erosion, ulceration, or irritation of these tissues. The dosage forms effectively deliver the risedronate to the lower intestinal tract, alleviating esophagitis or esophageal irritation that can occur with oral administration.

Career Highlights

William Kendall Sietsema is associated with The Procter & Gamble Company, where he has made significant contributions to pharmaceutical innovations. His work has been instrumental in enhancing the safety and effectiveness of medication delivery systems.

Collaborations

Throughout his career, Sietsema has collaborated with notable colleagues, including Richard John Dansereau and Russell Youker Mosher. These partnerships have fostered a collaborative environment that encourages innovation and the advancement of pharmaceutical technologies.

Conclusion

William Kendall Sietsema's innovative work in the field of pharmaceuticals demonstrates his commitment to improving medication delivery systems. His patents reflect a dedication to enhancing patient safety and treatment efficacy.